Patient info Open main menu

Maxitrol ointment – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
6000 unit/gram + 3500 unit/gram + 1 mg/gram
Contains active substances:
Similar medicines:

Patient leaflet - Maxitrol ointment

WHAT IT IS USED FOR

MAXITROL Ointment contains a steroid,

dexamethasone and two antibiotics,

neomycin sulphate and polymyxin B

sulphate.

It is used for the short term treatment of inflammation of the eye, when it is also considered that a bacterial eye infection could develop.

2. BEFORE YOU USE MAXITROL® OINTMENT

Do not use MAXITROL

Ointment...

  • If you have any type of infection of

    the eye that is not being treated. Use of

    steroids may make infections worse.

  • If you have a sticky discharge from

    your eye.

  • If you are allergic to dexamethasone,

    neomycin, polymyxin B or any of the

    other ingredients listed in section 6.

Ask your doctor for advice.

Take special care...

  • Do not inject or swallow this medicine.
  • Consult your doctor or pharmacist

    before using this medicine if you have

    a disorder causing a thinning of the

    eye tissues.

  • Consult your doctor or pharmacist if

    your eye pain, redness, swelling or

    irritation gets worse or persists.

  • If you experience allergic reactions with

    Maxitrol, discontinue use and consult

    your doctor. Allergic reactions may vary

    from localized itching or skin redness to

    severe allergic reactions (anaphylactic

    reaction) or serious skin reactions.

    These allergic reactions may occur with

    other topical or systemic antibiotics of

    the same family (aminoglycosides).

  • Steroids applied to the eye may

    delay the healing of your eye wound.

    Topical NSAIDs (Non-Steroidal Anti

    Inflammatory Drugs-Medications) are

    also known to slow or delay healing.

    Concomitant use of topical NSAIDs

    and topical steroids may increase the

    potential for healing problems.

  • If you use MAXITROL Ointment for a

    long time you may.

  • Have increased pressure in your eye(s).

    You should have your eye pressure

    checked regularly while using Maxitrol.

    This is especially important in children,

    as the risk of corticosteroid-induced

    increased pressure in the eye may

    be greater in children and may occur

    earlier than in adults. The risk of

    corticosteroid-induced increase

    intraocular pressure and/or cataract

    formation is increased in predisposed

    patients (e.g. diabetes).

  • Develop cataract.
  • Become more susceptible to eye

    infections.

  • Talk to your doctor if you experience

    swelling and weight gain around the

    trunk and in the face as these are

    usually the first manifestations of a

    syndrome called Cushing’s syndrome.

    Suppression of the adrenal gland

    function may develop after stopping a

    long-term or intensive treatment with

    MAXITROL. Talk to your doctor before

    stopping the treatment by yourself.

    These risks are especially important in children and patients treated with a drug called ritonavir or cobicistat.

    • Contact your doctor if you experience blurred vision or other visual disturbances.
    • Talk to your doctor before using Maxitrol Ointment if you have diabetes or have a family history of diabetes.

Pregnancy and breast-feeding

MAXITROL Ointment is not

recommended during pregnancy or breast-feeding. If you are pregnant or might get pregnant, or if you are breastfeeding a baby, talk to your doctor before you use MAXITROL Ointment.

Driving and using machines

MAXITROL Ointment may cause brief blurring of vision on instillation. If your sight is affected in any way you should not drive or operate machinery.

Using other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Taking MAXITROL Ointment with other medicines may increase the seriousness of any side effects. Especially tell your doctor if you are using:

  • Topical NSAIDs. Concomitant use of topical steroids and topical NSAIDs may increase corneal healing problems. Tell your doctor if you are using ritonavir or cobicistat, as this may increase the amount of dexamethasone in the blood. Tell your doctor if you are diabetic and you are taking, having recently taken or might take medicines for treatment of diabetes such as insulin, metformin or sulfonylureas such as chlorpropamide, as Maxitrol Ointment may decrease the blood glucose lowering effect of these medicines.

Important information if you wear Contact Lenses

Wearing contact lenses is not advisable during the treatment of an eye infection, as they may make the condition worse. If you do continue to wear your lenses, you must remove them before using MAXITROL Ointment and wait at least 15 minutes after use before putting your lenses back in.

Important information about some of the ingredients in MAXITROL Ointment

MAXITROL Ointment contains lanolin which may cause local skin reactions (e.g. contact dermatitis).

MAXITROL Ointment contains

parahydroxybenzoates which can cause allergic reactions, possibly delayed.

3. HOW TO USE MAXITROL® OINTMENT

The usual dose

The usual dose is to apply MAXITROL

Ointment 3 - 4 times daily.

The ointment may also be used at bedtime

while other eye drops are used during

the day.

Always use MAXITROL Ointment exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

How to use

  • Wash your hands

    before you start.

  • Remove the cap from

    the tube.

  • Tilt your head back.
  • Pull down your lower

    eyelid with a finger,

    until there is a

    'pocket' between the

    eyelid and your eye.

    The ointment will go

    in here (picture 1).

  • Bring the ointment

    tube close to the eye.

    Do this in front of a mirror if it helps.

  • Do not touch your eye or eyelid,

    surrounding areas or other surfaces

    with the tip of the tube. It could infect

    the ointment.

    • Gently squeeze a small ribbon of ointment into the pocket formed between your lower eyelid and your eye (picture 2).
    • Release the lower eyelid and blink a few times.
    • If you use ointment in both eyes, repeat the steps for your other eye. Replace and tightly close the cap on the tube.
    • If you miss a dose do not worry, just apply the next dose when it is due. Do not use a double dose to make up.
    • If you use more MAXITROL Ointment than you should do not worry, it is not likely to do any harm.
    • If this medicine is accidentally swallowed it is not likely to cause any serious problems.

If you are also using other eye drops

or eye ointment wait at least 5 minutes

after putting in the other medicine before

applying MAXITROL Ointment.

If you have any further questions on the use of MAXITROL Ointment, ask your doctor or pharmacist.

Continued over>

L616079 02 GB Technical approval by Packaging Site not using OneArt: electronic or handwritten signature. (If handwritten, it must be legible, include the approver’s full name and date of approval)

Creation date:

07 Aug 2024

ifier No. New: AW identifier No. Old: 079 02-GB 616079-GB
LFT_DEXAC_OINO_6000IU/G/3_ ALU_3.5G_GB
Packaging site: CM, ES, EL MASNOU, ALCON CUSI SA / SIEGFRIED (IM)

Tech. Drawing No.: MT0114-2

125 x 500 mm

Printing colours:

Print enhancements:

TextFree Black

N/A

Live text:

8 pt

N/A Yes

No

No

Both

Braille:N/A
! P L E A S E T U R N O V E R P R I N T I N G O N !

4. POSSIBLE SIDE EFFECTS

Like all medicines, MAXITROL Ointment can cause side effects, although not everybody gets them.

You may experience some or all of the following effects in your eyes: Uncommon (affect 1 to 10 users in 1000):

eye surface inflammation, increased pressure in eye, eye irritation, itching or discomfort.

Not Known (cannot be estimated from the available data):

corneal ulcer, blurred vision, sensitivity to light, increase in pupil size, drooping of eyelid, eye pain, eye swelling, abnormal sensation in the eye, eye redness, increased tear production, thinning of the surface of the eye.

You may also experience effects in other parts of your body:

Not known (cannot be estimated from the available data): allergy. Headache, serious skin reactions (Steven-Johnson syndrome).

Hormone problems: growth of extra body hair (particularly in women), muscle weakness and wasting, purple stretch marks on body skin, increased blood pressure, irregular or missing periods, changes in the levels of protein and calcium in your body, stunted growth in children and teenagers and swelling and weight gain of the body and face (called `Cushing's syndrome') (see section 2, "Warnings and precautions").

Steroids may be associated with an increase of blood glucose levels and diabetes.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard

5. HOW TO STORE MAXITROL® OINTMENT

  • Keep out of the reach and sight of children.
  • Do not refrigerate or store above 25°C.
  • Keep the tube tightly closed and keep out of direct sunlight.
  • Do not use the ointment after the expiry date (marked 'Exp') on the tube and the carton. The expiry date refers to the last day of that month.
  • Stop using the tube 4 weeks after first opening, to prevent infections.

    • Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
    • Do not pass this medicine on to others.
    • It may harm them, even if their symptoms are the same as yours.

6. FURTHER INFORMATION

What MAXITROL Ointment contains

  • The active substances are

    Dexamethasone 1 mg/g, Neomycin sulphate (as base) 3500 IU/g, Polymyxin B sulphate 6000 IU/g.

  • The other ingredients are methyl parahydroxybenzoate, propyl parahydroxybenzoate, liquid lanolin and white soft paraffin.

    What MAXITROL Ointment looks like and contents of the pack

    MAXITROL Ointment is a white to very pale yellow ointment supplied in a pack containing a 3.5 g metal tube with a screw cap.

Marketing authorisation holder and

manufacturer:

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place,

195 Wood Lane,

London,

W12 7FQ

United Kingdom.

This leaflet was last revised in 12/2021

L616079 02 GB

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00101/1001

Last revision stated in the text: December 2021 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Maxitrol ointment

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Dexamethasone, Polymyxin B sulfate, Neomycin sulfate
Strength 6000 unit/gram + 3500 unit/gram + 1 mg/gram
Pharmaceutical form Eye ointment
White to very pale yellow homogeneous translucent ointment
How is it taken Ocular
Excipients Methylparaben, Propylparaben, Liquid lanolin, Petrolatum
Pack sizes 3.5 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Discard 28 days after first opening.
Storage Do not store above 25°C. Keep away from direct sunlight. Do not refrigerate. Keep the container tightly closed.
Drug group (ATC) Ophthalmologicals; anti-infectives
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01C Antiinflammatory agents and antiinfectives in combination
        1. S01CA Corticosteroids and antiinfectives in combination, opthalmologic
          1. S01CA01 dexamethasone and antiinfectives
Marketing authorisation PL 00101/1001 (first authorised 18 January 1991)
Marketing authorisation holder Novartis Pharmaceuticals UK Limited
Codes GTIN 5010678913255 · BNF 11040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.